GlassScriptPhysician profile
Mary Jo Stiegemeier
NPI 1598767337
$5,442.15
in general payments reported to CMS, 2019-2025
15 companies · $22.82 in 2025
The $22.82 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,144 · 2020: $12.52 · 2021: $30.24 · 2022: $232 · 2025: $22.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,714.54 | 2019 | |
| Alcon Vision LLC | $2,255.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $129.87 | 2019-2022 | |
| Allergan, INC. | $48.92 | 2019-2022 | |
| Oyster Point Pharma, INC. | $45.34 | 2022 | |
| Bausch & Lomb Americas INC. | $44.67 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $39.02 | 2019 | |
| Sun Pharmaceutical Industries INC. | $30.74 | 2019-2020 | |
| Abbvie INC. | $28.07 | 2022 | |
| Visioneering Technologies, INC. | $24.85 | 2019 | |
| Biotissue Holdings INC. | $22.82 | 2025 | |
| Alcon Research LLC | $16.82 | 2019 | |
| Shire North American Group INC | $15.71 | 2019 | |
| Kala Pharmaceuticals, INC. | $14.76 | 2022 | |
| Coopervision INC. | $11.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Jo Stiegemeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.